Related references
Note: Only part of the references are listed.Impact of adalimumab treatment on cardiovascular risk biomarkers in psoriasis: Results of a pilot study
Spyridon Gkalpakiotis et al.
JOURNAL OF DERMATOLOGY (2017)
Asymmetric dimethylarginine but not osteoprotegerin correlates with disease severity in patients with moderate-to-severe psoriasis undergoing anti-tumor necrosis factor-α therapy
Trinitario Pina et al.
JOURNAL OF DERMATOLOGY (2016)
Anti-TNF-α therapy reduces retinol-binding protein 4 serum levels in non-diabetic patients with psoriasis: a 6-month prospective study
T. Pina et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
Emerging Cardiovascular Disease Biomarkers and Incident Diabetes Mellitus Risk in Statin-Treated Patients With Coronary Artery Disease (from the Treating to New Targets [TNT] Study)
Benoit J. Arsenault et al.
AMERICAN JOURNAL OF CARDIOLOGY (2016)
Anti-tumor necrosis factor-alpha therapy improves endothelial function and arterial stiffness in patients with moderate to severe psoriasis: A 6-month prospective study
Trinitario Pina et al.
JOURNAL OF DERMATOLOGY (2016)
Targeting Tumor Necrosis Factor-α with Adalimumab: Effects on Endothelial Activation and Monocyte Adhesion
Raghav Oberoi et al.
PLOS ONE (2016)
Association of Trabecular Bone Score with Inflammation and Adiposity in Patients with Psoriasis: Effect of Adalimumab Therapy
Jose L. Hernandez et al.
JOURNAL OF OSTEOPOROSIS (2016)
Relationship of Leptin with adiposity and inflammation and Resistin with disease severity in Psoriatic patients undergoing anti-TNF-alpha therapy
T. Pina et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Anti-TNF-α therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients
Fernanda Genre et al.
RHEUMATOLOGY INTERNATIONAL (2015)
Anti-TNF- therapy improves insulin sensitivity in non-diabetic patients with psoriasis: a 6-month prospective study
T. Pina et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Cardiovascular Risk and Psoriasis: Beyond the Traditional Risk Factors
Ann G. Coumbe et al.
AMERICAN JOURNAL OF MEDICINE (2014)
Rheumatoid arthritis and metabolic syndrome
Gyoergy Kerekes et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Adipokines, Biomarkers of Endothelial Activation, and Metabolic Syndrome in Patients with Ankylosing Spondylitis
Fernanda Genre et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Platelet activation: a link between psoriasis per se and subclinical atherosclerosis - a case-control study
H. M. A. Saleh et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Impact of effective tumor necrosis factor-alfa inhibitor treatment on arterial intima-media thickness in psoriasis: Results of a pilot study
Hajnalka Jokai et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
Pathogenic Mechanisms Shared between Psoriasis and Cardiovascular Disease
Ramin Ghazizadeh et al.
International Journal of Medical Sciences (2012)
Atherogenic Index and High-Density Lipoprotein Cholesterol as Cardiovascular Risk Determinants in Rheumatoid Arthritis: The Impact of Therapy with Biologicals
Calin D. Popa et al.
MEDIATORS OF INFLAMMATION (2012)
Obese Mexican American Children Have Elevated MCP-1, TNF-α, Monocyte Concentration, and Dyslipidemia
Whitney L. Breslin et al.
PEDIATRICS (2012)
Platelet P-selectin reflects a state of cutaneous inflammation: possible application to monitor treatment efficacy in psoriasis
Jurate Garbaraviciene et al.
EXPERIMENTAL DERMATOLOGY (2010)
Platelet activation in patients with psoriasis: Increased plasma levels of platelet-derived microparticles and soluble P-selectin
Risa Tamagawa-Mineoka et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Cytokine profiles during infliximab monotherapy in psoriatic arthritis
A Mastroianni et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
TNFα therapy in psoriatic arthritis and psoriasis
P Mease
ANNALS OF THE RHEUMATIC DISEASES (2004)
Share Paper
